Dr. Bardon serves as managing member and portfolio manager at Burrage Capital Management. Prior to founding Burrage in 2010, Dr. Bardon was an equity analyst at Pyramis Global Advisors, the institutional investor arm of Fidelity Investments, where she formally covered biotechnology, life science tools, medical diagnostics, and technology across the entire market cap spectrum on a global basis.
Prior to joining Pyramis, Dr. Bardon started her investment career as a principal/analyst at MPM Capital, a biotech venture capital firm. At MPM, she identified and evaluated private and public investment opportunities, led due diligence teams (particularly in Europe), and served as a board observer at several portfolio companies. She also served as a Kauffman Foundation Fellow.
After completing medical school, Dr. Bardon also completed a residency in internal medicine at Brigham and Women’s Hospital. While at Harvard Medical School, where she conducted genetic research in immunology with Professor Frederick W. Alt, she was the recipient of a Howard Hughes Medical Institute fellowship.
Dr. Bardon currently serves on the board of fellows at Harvard Medical School and is a trustee of the American Association for Cancer Research Foundation.